IRIS
FARINA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 756
NA - Nord America 741
EU - Europa 731
SA - Sud America 117
AF - Africa 9
AN - Antartide 1
Totale 2.355
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 706
SG - Singapore 318
CN - Cina 277
RO - Romania 263
IT - Italia 135
SE - Svezia 114
BR - Brasile 101
DE - Germania 76
HK - Hong Kong 75
RU - Federazione Russa 29
CA - Canada 26
FI - Finlandia 25
VN - Vietnam 25
GB - Regno Unito 23
FR - Francia 19
IN - India 10
JP - Giappone 10
PL - Polonia 10
NL - Olanda 9
AT - Austria 8
AR - Argentina 7
MX - Messico 7
BD - Bangladesh 6
ID - Indonesia 6
IE - Irlanda 6
ZA - Sudafrica 6
LT - Lituania 5
PH - Filippine 5
TR - Turchia 5
EG - Egitto 3
ES - Italia 3
IQ - Iraq 3
AM - Armenia 2
AZ - Azerbaigian 2
BE - Belgio 2
CO - Colombia 2
IR - Iran 2
PK - Pakistan 2
PY - Paraguay 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
AQ - Antartide 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
IL - Israele 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
PE - Perù 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 2.355
Salva come PNG Salva come JPEG
Città #
Dallas 216
Singapore 162
Ashburn 90
Hong Kong 75
Shanghai 73
Beijing 57
Munich 47
Hefei 36
Milan 36
New York 31
Los Angeles 29
Lawrence 20
Princeton 20
Boardman 19
Helsinki 16
Rome 16
Moscow 15
Montreal 13
Atlanta 11
São Paulo 11
Ho Chi Minh City 10
Nuremberg 9
Warsaw 9
Houston 8
Toronto 8
Brooklyn 7
Cesano Boscone 7
Chicago 7
Amsterdam 6
Orem 6
Tokyo 6
Turku 6
Frankfurt am Main 5
Guangzhou 5
Johannesburg 5
London 5
Santa Clara 5
Shenzhen 5
Ancona 4
Ankara 4
Boston 4
Denver 4
Hanoi 4
Quezon City 4
Seattle 4
Stockholm 4
The Dalles 4
Baie-D'Urfé 3
Ballincollig 3
Chennai 3
Dublin 3
Falkenstein 3
Jundiaí 3
Osimo 3
Poli 3
Poplar 3
Pune 3
Rio de Janeiro 3
Salvador 3
San Giuliano 3
Vittoria 3
York 3
Aobadai 2
Assago 2
Bauru 2
Belo Horizonte 2
Bexley 2
Bosco Chiesanuova 2
Brescia 2
Cairo 2
Campinas 2
Castel Mella 2
City of London 2
Concórdia 2
Council Bluffs 2
Dalmine 2
Diadema 2
Fermo 2
Florence 2
Ghent 2
Hangzhou 2
Honcho 2
Jakarta 2
Joinville 2
Kansas City 2
Lappeenranta 2
Manchester 2
Mexico City 2
Milwaukee 2
New Delhi 2
Orlando 2
Phoenix 2
Pittsburgh 2
Rio Bonito 2
Roubaix 2
San Antonio 2
Tashkent 2
Turin 2
Venice 2
Verona 2
Totale 1.269
Salva come PNG Salva come JPEG
Nome #
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 325
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 147
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 94
Biobanking for COVID-19 research 84
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 82
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 77
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 77
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 72
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 67
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 65
Obesity and its role in the management of rheumatoid and psoriatic arthritis 64
Drug retention rates of biological agents in adult onset Still's disease 64
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 63
COVID-19: Pharmacology and kinetics of viral clearance 62
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 61
Current treatment options and safety considerations when treating adult-onset Still’s disease 60
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 59
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 59
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 57
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 57
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 56
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 55
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 50
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 49
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 47
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 46
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year 45
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 42
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 41
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 40
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 40
Low prevalence of arrhythmias in clinically stable COVID-19 patients 38
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 35
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study 35
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 32
Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle 31
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease 26
Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease 21
Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort 19
Totale 2.444
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 6 4 1 0 0 2 1
2021/202248 1 0 12 14 2 0 1 1 6 7 0 4
2022/2023216 50 43 16 6 12 25 20 25 4 2 6 7
2023/2024242 11 26 32 27 26 28 14 27 0 4 13 34
2024/2025909 56 15 21 28 42 50 358 66 92 36 47 98
2025/20261.000 169 167 183 286 181 14 0 0 0 0 0 0
Totale 2.444